Celltrion, Inc. (KRX:068270)
South Korea flag South Korea · Delayed Price · Currency is KRW
199,300
+4,300 (2.21%)
At close: Aug 7, 2026

Celltrion Revenue

Celltrion had revenue of 1.14T KRW in the quarter ending March 31, 2026, with 36.00% growth. This brings the company's revenue in the last twelve months to 4.47T, up 21.94% year-over-year. In the year 2025, Celltrion had annual revenue of 4.16T with 17.01% growth.

Revenue (ttm)
4.47T
Revenue Growth
+21.94%
P/S Ratio
10.23
Revenue / Employee
1.67B
Employees
2,680
Market Cap
45.70T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.16T605.19B17.01%
Dec 31, 20243.56T1.38T63.45%
Dec 31, 20232.18T-107.54B-4.71%
Dec 31, 20222.28T390.57B20.63%
Dec 31, 20211.89T44.29B2.39%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Samsung Biologics4.81T
Samsung Epis Holdings1.51T
SK Biopharmaceuticals790.25B
SK bioscience665.42B
Hugel451.93B
ALTEOGEN203.76B
LigaChem Biosciences125.87B
ABL Bio90.32B
Revenue Rankings